Literature DB >> 20465705

Large-scale worldwide observational study of adherence with acne therapy.

Brigitte Dréno1, Diane Thiboutot, Harald Gollnick, Andrew Y Finlay, Alison Layton, James J Leyden, Eric Leutenegger, Montserrat Perez.   

Abstract

Acne is a common chronic disease that typically requires prolonged treatment. Several small studies conducted over the past few years suggest that adherence to acne medications is often poor. In addition, data regarding the factors that positively or negatively impact adherence in patients with acne are sparse. This study utilized a simple, validated questionnaire (ECOB, Elaboration d'un outil d'evaluation de l'observance des traitements medicamenteux) to assess the risk of poor adherence in a large worldwide cohort of acne patients (n = 3339) from three major geographic regions [the Americas (n = 952), Europe (n = 1196), and Asia (n = 1191). In addition, information about patient and treatment characteristics was collected to identify factors that correlated with adherence. Overall, there was a poor adherence rate of 50% in this study; this varied by region, with significantly worse adherence in Europe versus Asia and America (poor adherence rates of 58%, 48%, and 43%, respectively, P < 0.0001). To provide insight into factors that affect medication-taking behavior in acne, adherence was analyzed by the type of treatment (a combination of topical and systemic, topical only, oral isotretinoin). Among patients taking a combination of both systemic and topical therapy, 60% (n = 944) of patients had poor adherence to at least one treatment as defined in the study protocol. In this group, there was a higher proportion of patients who had poor adherence to systemic treatment versus topical treatment (54% vs. 44%, respectively). Among patients treated with topical therapy only, poor adherence occurred in 40% (n = 356) of cases. A total of 46% (n = 325) of patients using oral isotretinoin therapy had poor adherence. Multivariate analysis showed that poor adherence was independently correlated with young age (most strongly with <15 years but also in the age group from 15 to 25 years), the occurrence of side effects, lack of improvement as evaluated by dermatologist, previous systemic therapy, lack of knowledge about acne treatment, consultation with a primary care physician, and lack of patient satisfaction with treatment. Factors that had a positive effect on adherence were more severe acne, use of cosmetics (moisturizers, cleansers), use of either topical therapy alone or isotretinoin, good clinical improvement as evaluated by the dermatologist, patient satisfaction with therapy, and knowledge of acne treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20465705     DOI: 10.1111/j.1365-4632.2010.04416.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  40 in total

Review 1.  50 Years of Topical Retinoids for Acne: Evolution of Treatment.

Authors:  Hilary Baldwin; Guy Webster; Linda Stein Gold; Valerie Callender; Fran E Cook-Bolden; Eric Guenin
Journal:  Am J Clin Dermatol       Date:  2021-05       Impact factor: 7.403

2.  The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions.

Authors:  James J Leyden; James Q Del Rosso; Eric W Baum
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

3.  Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.

Authors:  Linda Stein Gold; James Q Del Rosso; Leon Kircik; Neal D Bhatia; Deirdre Hooper; Walter Nahm; Iain Stuart
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

4.  Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials.

Authors:  Diane M Thiboutot; Leon Kircik; Amy McMichael; Fran E Cook-Bolden; Stephen K Tyring; David R Berk; Joan-En Chang-Lin; Vince Lin; Alexandre Kaoukhov
Journal:  J Clin Aesthet Dermatol       Date:  2016-10-01

5.  Microsphere technology: hype or help?

Authors:  Leon H Kircik
Journal:  J Clin Aesthet Dermatol       Date:  2011-05

6.  The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications.

Authors:  Kira L Ryskina; Erica Goldberg; Briana Lott; Davis Hermann; John S Barbieri; Jules B Lipoff
Journal:  JAMA Dermatol       Date:  2018-04-01       Impact factor: 10.282

7.  Generic, twice-daily minocycline versus branded, extended-release minocycline for acne: A retrospective comparison of treatment escalation.

Authors:  Preeta Gupta; Timothy Shin; Jennifer Sopkovich; Susan Massick; Benjamin H Kaffenberger
Journal:  J Am Acad Dermatol       Date:  2017-06       Impact factor: 11.527

8.  Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and benzoyl peroxide (3.75%) aqueous gel in moderate or severe adolescent acne vulgaris.

Authors:  Fran E Cook-Bolden
Journal:  J Clin Aesthet Dermatol       Date:  2015-05

Review 9.  Light therapies for acne.

Authors:  Jelena Barbaric; Rachel Abbott; Pawel Posadzki; Mate Car; Laura H Gunn; Alison M Layton; Azeem Majeed; Josip Car
Journal:  Cochrane Database Syst Rev       Date:  2016-09-27

10.  Sub-group Analyses from a Trial of a Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Gel for the Treatment of Moderate-to-severe Acne Vulgaris.

Authors:  Michael H Gold; Andrew Korotzer
Journal:  J Clin Aesthet Dermatol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.